Burns: would tilapia skin be a more economical and effective alternative for the SUS compared to traditional treatment?
DOI:
https://doi.org/10.17564/2316-3798.2023v9n2p278-291
Published
Downloads
Downloads
Issue
Section
License
Copyright (c) 2023 Interfaces Científicas - Saúde e Ambiente
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
a. Autores mantêm os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
b. Autores têm permissão e são estimulados a distribuir seu trabalho on-line (ex.: em repositórios institucionais ou na sua página pessoal), já que isso pode gerar aumento o impacto e a citação do trabalho publicado (Veja O Efeito do Acesso Livre).
Abstract
A large number of burns are treated every single year in the Brazilian public healthcare system, known as SUS, being treated mainly with silver sulfadiazine cream. More recent studies, however, draw attention to the prominence of biological dressings, especially xenografts in the treatment of burns. Nile tilapia skin recently became the first animal xenograft approved by ANVISA in Brazil. The method used in this study was an integrative literature review, with the aim of understanding the feasibility of using tilapia skin xenografts as a biological dressing for the treatment of burns, evaluating its efficacy and safety, conjecturing a possible use on a large scale in the SUS. It was verified the safety and applicability of the tilapia skin biological dressing as a treatment for burns and, with the emergence of new studies, the feasibility of its use in SUS becomes increasingly possible, verifying a good cost ratio-benefit.
